Related Experiment Videos
Lipoproteins and cardiovascular risk-from genetics to CHD prevention
1Institute of Arteriosclerosis Research, University of Münster, Germany.
Insights
Dyslipidemia, characterized by abnormal lipid levels, arises from genetic and environmental factors. It can lead to atherosclerosis and is often influenced by other health conditions.
Area of Science:
- Cardiovascular Science
- Genetics
- Metabolic Disorders
Background:
- Dyslipidemia involves abnormal lipid or lipoprotein levels linked to atherosclerosis.
- It can manifest as severe deviations from normal lipid profiles.
- Epidemiological studies define lipid ranges associated with secondary complications.
Purpose of the Study:
- To define dyslipidemia based on lipid levels and associated complications.
- To explore the multifactorial causes of dyslipidemia, including genetic and environmental influences.
- To examine the role of secondary conditions in exacerbating or unmasking lipid disorders.
Main Methods:
- Analysis of epidemiological data to establish lipid level associations.
- Identification of genetic factors, including polygenic and monogenic causes.
- Review of clinical cases involving secondary hyperlipidemia and genetic interactions.
Main Results:
- Dyslipidemia is often caused by a combination of polygenes and environmental factors.
- Monogenic mutations can cause severe dyslipidemia phenotypes.
- Secondary conditions like hypothyroidism and diabetes mellitus can unmask or worsen genetic lipid disorders.
Conclusions:
- Dyslipidemia is a complex condition with diverse etiologies.
- Genetic predisposition and environmental factors interact to influence lipid profiles.
- Understanding secondary causes is crucial for managing dyslipidemia effectively.
Abstract:
Dyslipidemia is said to be present when lipid or lipoprotein levels lie within a range which is known from epidemiological studies to be associated with secondary complications, in particular atherosclerosis of the coronary arteries, or when a lipid or lipoprotein grossly deviates from the norm as in abetalipoproteinemia, hypobetalipoproteinemia or the HDL deficiency syndromes. In most cases, dyslipidemia is due not to a single genetic or environmental factor, but to a combination of the effects of several genes of small effect (polygenes) and environment. In other cases, however, dyslipidemia is caused by a mutation in a single gene of large effect. In such cases, the extent and nature of the phenotype depends primarily on the identity of the gene involved, but is also modulated to an important degree by the nature of the mutation and the genetic and environmental background against which this mutation occurs. In addition, many cases of hyperlipidemia are secondary to other disorders such as hypothyroidism or renal dysfunction. Such disorders may also unmask or exacerbate a genetic lipoprotein disorder. Examples of the latter are the unmasking of type III hyperlipidemia by diabetes mellitus or the exacerbation of familial hypercholesterolemia by hypothyroidism.